Terren K. Niethamer, Ph.D.
- Center for Cancer Research
- National Cancer Institute
- Building 560, Room 21-9
- Frederick, MD 21702-1201
- 301-846-6515
- terren.niethamer@nih.gov
RESEARCH SUMMARY
I am a cell and developmental biologist fascinated by endothelial cells, which line blood vessels in the lung. The goal of my research program is to understand how endothelial cells communicate with other lung cells to build complex three-dimensional structures during development and regeneration. Answering this question will help us determine how tissue structures are built and rebuilt and how this process can go wrong in the diseased or injured lung.
Areas of Expertise
Research
My original inspiration to study endothelial cells came from my interest in lung alveolar structure and its connection to function. I am fascinated by the beautiful three-dimensional structure of the gas exchange interface in the lung, in which the large, flat alveolar type 1 epithelial cell overlays the capillary network lined with endothelium. How do endothelial cells contribute to development and regeneration of this complex structure? This question is essential to the pursuit of improved regenerative therapies for patients with lung disease.
Single-cell genomics has revolutionized our understanding of the heterogeneity of lung cell types during development, maintenance of homeostasis and disease. These experiments have identified novel cell types and provided great insight into the mechanisms of lung repair. In addition, analysis of the epigenome using the assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) and single-cell ATAC-seq have provided unprecedented opportunities to understand the factors that define cell fates at the single-cell level. To develop much-needed regenerative therapies in the lung, however, it will be essential to understand not only how cell fates are defined, but also how three-dimensional tissue architecture is formed.
My research program integrates genomic techniques, ex vivo approaches in mouse and human primary cells and tissue, and mouse genetics to develop a fundamental understanding of how endothelial cells communicate with other cell types in the lung alveolar niche to drive development, maintain homeostasis and effect repair after injury. I am particularly interested in the role of endothelial signaling in tissue morphogenesis. Our work will improve understanding of mechanisms of cellular self-organization and tissue morphogenesis in lung development and regeneration by:
- Expanding our knowledge of how lung endothelial cell fates are established and maintained
- Determining how endothelial cell signaling affects alveolar development and repair
- Defining the impact of endothelial cell signaling on alveolar tissue organization
The long-term goal of my group is to benefit lung and vascular biology, as well as society, by using the scientific knowledge we gain to improve therapies for human lung and vascular disease.
Publications
Genomic, epigenomic, and biophysical cues controlling the emergence of the lung alveolus
Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury
Aberrant cell segregation in the craniofacial primordium and the emergence of facial dysmorphology in craniofrontonasal syndrome
EPHRIN-B1 Mosaicism Drives Cell Segregation in Craniofrontonasal Syndrome hiPSC-Derived Neuroepithelial Cells
Biography
Terren K. Niethamer, Ph.D.
My interest in the connection between form and function has led me to pursue research questions in several different disciplines, including synthetic chemistry, glycan biosynthesis, craniofacial morphogenesis, and lung regeneration. Throughout my research career, I have been inspired by both the thrill of scientific discovery and the knowledge that my work can tangibly benefit patients. I obtained a Ph.D. in Biomedical Sciences from the University of California, San Francisco, where I worked in the laboratory of Dr. Jeffrey Bush and received support from an NSF Graduate Research Fellowship and an F31 predoctoral fellowship. My graduate work focused on the role of ephrin-B1 signaling in cell self-organization, tissue morphogenesis, and congenital disease, expanding our understanding of the role of Eph/ephrin signaling in cell behavior. This ignited my enthusiasm for studying signaling mechanisms in cell behavior and morphogenesis during development and regeneration.
I trained as a postdoctoral fellow in the laboratory of Dr. Edward Morrisey at the University of Pennsylvania, where I defined the cellular composition of the pulmonary capillary endothelium and began to elucidate the functional role of endothelial heterogeneity in lung regeneration, a question that I continue to pursue today. I identified an essential role for the transcription factor ATF3 in lung regeneration and demonstrated that repair of the capillary vascular network is key to restoring the structural integrity of the lung alveolus. I received several presentation awards for this work and successfully competed for NIH funding, including an F32 postdoctoral fellowship and a K99 career development award. My current research builds on my postdoctoral work to determine the role of endothelial cell signaling in development and regeneration of the lung alveolus and its gas exchange function.
I am driven by the desire to pursue deeper scientific knowledge and use it to improve treatments for human disease, but also by the goal of making these pursuits more accessible to groups who have been historically excluded from biomedical science. By creating an environment that is collaborative, welcoming, and inclusive to all, I believe we will do better science, have more fun, and have a greater positive impact on human health.
Team
News
Learn more about CCR research advances, new discoveries and more
on our news section.
Gallery
Niethamer Lab - August, 2024. L-R: Arnav Sharma, Karolina Haryanto, Terren Niethamer, Dylan Rothbort, Sachin Gaurav, Michael Sanford.
NIH Summer Intern Poster Day, NIH Campus, Aug. 2, 2024. Presenting: Karolina Haryanto, B.S. (Niethamer Lab)
